LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
LENSAR, Inc.NASDAQ: LNSR
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash turns negative
Q1 FY2026 net change in cash was -$480K, compared with $3.28M a year earlier. Trailing-twelve-month net change in cash was -$7.05M. Over 3 fiscal years it compounded at -42.1% a year.
Context
- Net change in cash amounted to 5.6% of revenue in FY2025, down 2.5 pp from a year earlier.
- Net change in cash increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly net change in cash holds near -$480K or moves back toward the trailing-twelve-month quarterly average of -$1.76M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- (3.29M) USD
- Year-over-year change
- +24.5%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.29M) | +24.5% |
| FY2024 | 2024-12-31 | (4.36M) | -173.3% |
| FY2023 | 2023-12-31 | 5.95M | +135.1% |
| FY2022 | 2022-12-31 | (16.96M) | -89.3% |
| FY2021 | 2021-12-31 | (8.96M) | — |
Net Change in Cash vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 net change in cash of $7.05M is the 7th largest of the 10 companies compared; the peer median is $3.75M.
- Its year-over-year change of -226.2% is the 8th highest of 10, against a peer median of +35.0%.
- Net change in cash amounts to 12.2% of revenue for LNSR, versus a peer median of 25.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $234.26M | +457.2% | +111.7% | 12655.6% |
| LTM Mar 2026 | $43.55M | +382.3% | — | 97.0% | |
| LTM Mar 2026 | $24.49M | +1470.5% | — | 22.9% | |
| LTM Mar 2026 | $15.55M | -386.0% | — | 2962.1% | |
| LTM Mar 2026 | $12.35M | -19.1% | — | 10.6% | |
| LTM Mar 2026 | $8.83M | -877.1% | -40.3% | 27.3% | |
| LTM Mar 2026 | $7.05M | -226.2% | -42.1% | 12.2% | |
| LTM Mar 2026 | $6.48M | +35.0% | — | — | |
| LTM Mar 2026 | $5.09M | +47.7% | — | 14.8% | |
| LTM Mar 2026 | $3.75M | -28.6% | — | 19.9% | |
| Peer median (excluding LNSR) | $3.75M | +35.0% | +35.7% | 25.1% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| Deferred Income Tax | 527K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.87M | 6.61M | 5.54M | 2.67M | 3.14M |
| Change in Working Capital | (42K) | (5.58M) | (7.78M) | (3.04M) | 1.1M |
| Accounts Receivables | (2.65M) | (1.44M) | 1.08M | (2.1M) | 289K |
| Inventory | 2.33M | (6.89M) | (7.46M) | (4.9M) | (13.9M) |
| Accounts Payables | 213K | 2.73M | (1.42M) | 1.96M | 12.99M |
| Other Working Capital | 66K | 23K | 23K | 2M | 1.72M |
| Other Non-Cash Items | 517K | 618K | 3.45M | 25.58M | 10.7M |
| Operating Cash Flow | (8.97M) | (14.86M) | (9.66M) | (2.28M) | (14.83M) |
| Capital Expenditures | (354K) | (115K) | (236K) | (156K) | (83K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (3.92M) | (10.25M) | (11.88M) |
| Sales of Investments | 0 | 0 | 0 | 8.24M | 13.25M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (354K) | (115K) | (4.16M) | (2.16M) | 1.28M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 361K | 408K | 0 | 58K | 258K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (2.4M) | 5.88M | 20K | 10M |
| Financing Cash Flow | 361K | (1.99M) | 19.76M | 78K | 10.26M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.96M) | (16.96M) | 5.95M | (4.36M) | (3.29M) |
| Free Cash Flow | (9.32M) | (14.97M) | (9.9M) | (2.43M) | (14.91M) |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.